Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population

Mutagenesis

Volumn 31, Issue 5, 2016, Pages 531-538

  Hua, Qiuhan ^a   Lv, Xu ^b   Gu, Xiang ^c   Chen, Yaoyao ^a   Chu, Haiyan ^a   Du, Mulong ^a   Gong, Weida ^b   Wang, Meilin ^a   Zhang, Zhengdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Yixing Tumor Hospital   (China)

^c Aoyang Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG NONCODING RNA H19; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; H19 LONG NON-CODING RNA;

ADULT; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN GENOME PROJECT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLADDER TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RNA, LONG NONCODING; URINARY BLADDER NEOPLASMS;

EID: 84985940544     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gew018     Document Type: Article

References (47)

1. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., and Bray, F. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136, E359-E386.
2. Yang, L., Parkin, D. M., Li, L. D., Chen, Y. D., and Bray, F. (2004) Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer, 90, 2157-2166.
3. Globocan 2012 Home Page http://globocan.iarc.fr (accessed on October 7 2014).
4. Golka, K., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Marchan, R., Ickstadt, K., Schwender, H., Bolt, H. M., and Hengstler, J. G. (2011) Genetic variants in urinary bladder cancer: collective power of the " wimp SNPs " . Arch. Toxicol., 85, 539-554.
5. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-Analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
6. Kiemeney, L. A., Thorlacius, S., Sulem, P., et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
7. Kiemeney, L. A., Sulem, P., Besenbacher, S., et al. (2010) A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet., 42, 415-419.
8. Figueroa, J. D., Ye, Y., Siddiq, A., et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet., 23, 1387-1398.
9. Kung, J. T., Colognori, D., and Lee, J. T. (2013) Long noncoding RNAs: past, present, and future. Genetics, 193, 651-669.
10. Qi, P., and Du, X. (2013) The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol., 26, 155-165.
11. Fatica, A., and Bozzoni, I. (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet., 15, 7-21.
12. Huarte, M., and Rinn, J. L. (2010) Large non-coding RNAs: missing links in cancer? Hum. Mol. Genet., 19, R152-R161.
13. Guffanti, A., Iacono, M., Pelucchi, P., et al. (2009) A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics, 10, 163.
14. Lin, R., Maeda, S., Liu, C., Karin, M., and Edgington, T. S. (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene, 26, 851-858.
15. Kogo, R., Shimamura, T., Mimori, K., et al. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res., 71, 6320-6326.
16. Ying, L., Chen, Q., Wang, Y., Zhou, Z., Huang, Y., and Qiu, F. (2012) Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-To-mesenchymal transition. Mol. Biosyst., 8, 2289-2294.
17. Ying, L., Huang, Y., Chen, H., Wang, Y., Xia, L., Chen, Y., Liu, Y., and Qiu, F. (2013) Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol. Biosyst., 9, 407-411.
18. Han, Y., Liu, Y., Gui, Y., and Cai, Z. (2013) Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J. Surg. Oncol., 107, 555-559.
19. Wang, X. S., Zhang, Z., Wang, H. C., et al. (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin. Cancer Res., 12, 4851-4858.
20. Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., and Qiu, J. (2013) Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J., 280, 1709-1716.
21. Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., and Qiu, J. (2013) Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett., 333, 213-221.
22. Xue, Y., Ma, G., Zhang, Z., et al. (2015) A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget, 6, 484-493.
23. Verhaegh, G. W., Verkleij, L., Vermeulen, S. H., den Heijer, M., Witjes, J. A., and Kiemeney, L. A. (2008) Polymorphisms in the H19 gene and the risk of bladder cancer. Eur. Urol., 54, 1118-1126.
24. Koukoura, O., Sifakis, S., Zaravinos, A., Apostolidou, S., Jones, A., Hajiioannou, J., Widschwendter, M., and Spandidos, D. A. (2011) Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction. Placenta, 32, 51-57.
25. Park, J. Y., Lee, J. E., Park, J. B., Yoo, H., Lee, S. H., and Kim, J. H. (2014) Roles of long non-coding RNAs on tumorigenesis and glioma development. Brain Tumor Res. Treat., 2, 1-6.
26. Reik, W., and Walter, J. (2001) Genomic imprinting: parental influence on the genome. Nat. Rev. Genet., 2, 21-32.
27. Gao, T., He, B., Pan, Y., Gu, L., Chen, L., Nie, Z., Xu, Y., Li, R., and Wang, S. (2014) H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway. Clin. Transl. Oncol., 16, 410-417.
28. Xue, Y., Gu, D., Ma, G., et al. (2015) Genetic variants in lncRNA HOTAIR are associated with risk of colorectal cancer. Mutagenesis, 30, 303-310.
29. Liu, Y., Pan, S., Liu, L., et al. (2012) A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One, 7, e35145.
30. Adkins, R. M., Somes, G., Morrison, J. C., Hill, J. B., Watson, E. M., Magann, E. F., and Krushkal, J. (2010) Association of birth weight with polymorphisms in the IGF2, H19, and IGF2R genes. Pediatr. Res., 68, 429-434.
31. Yang, C., Tang, R., Ma, X., Wang, Y., Luo, D., Xu, Z., Zhu, Y., and Yang, L. (2015) Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget, 6, 15311-15320.
32. Wang, M., Chu, H., Li, P., et al. (2012) Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Res., 72, 6173-6182.
33. Wang, M., Chu, H., Lv, Q., et al. (2014) Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer. Int. J. Cancer, 135, 2653-2660.
34. Wu, H., Zheng, J., Deng, J., Hu, M., You, Y., Li, N., Li, W., Lu, J., and Zhou, Y. (2013) A genetic polymorphism in lincRNA-uc003opf.1 is associated with susceptibility to esophageal squamous cell carcinoma in Chinese populations. Carcinogenesis, 34, 2908-2917.
35. Ariel, I., Sughayer, M., Fellig, Y., et al. (2000) The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol. Pathol., 53, 320-323.
36. Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., and Galun, E. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS One, 2, e845.
37. Huang, C., Cao, L., Qiu, L., et al. (2015) Upregulation of H19 promotes invasion and induces epithelial-To-mesenchymal transition in esophageal cancer. Oncol. Lett., 10, 291-296.
38. Odefrey, F., Stone, J., Gurrin, L. C., et al.; Australian Twins and Sisters Mammographic Density Study. (2010) Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res., 70, 1449-1458.
39. Gong, W. J., Yin, J. Y., Li, X. P., Fang, C., Xiao, D., Zhang, W., Zhou, H. H., Li, X., and Liu, Z. Q. (2016) Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumour Biol, doi:10.1007/s13277-015-4497-5.
40. Raveh, E., Matouk, I. J., Gilon, M., and Hochberg, A. (2015) The H19 Long non-coding RNA in cancer initiation, progression and metastasis-A proposed unifying theory. Mol. Cancer, 14, 184.
41. Gao, W., Zhu, M., Wang, H., et al. (2015) Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat. Res., 772, 15-22.
42. Rafnar, T., Sulem, P., Stacey, S. N., et al. (2009) Sequence variants at the TERTCLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
43. Wu, X., Ye, Y., Kiemeney, L. A., et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet., 41, 991-995.
44. Rothman, N., Garcia-Closas, M., Chatterjee, N., et al. (2010) A multistage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet., 42, 978-984.
45. Garcia-Closas, M., Ye, Y., Rothman, N., et al. (2011) A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet., 20, 4282-4289.
46. Rafnar, T., Vermeulen, S. H., Sulem, P., et al. (2011) European genomewide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet., 20, 4268-4281.
47. Wang, M., Qin, C., Zhu, J., Yuan, L., Fu, G., Zhang, Z., and Yin, C. (2010) Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol., 29, 303-311.